| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 10/02/2002 | EP1244780A2 Dna encoding the human serine protease t |
| 10/02/2002 | EP1244778A2 Human heparanase-related polypeptide and nucleic acid |
| 10/02/2002 | EP1244774A2 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same |
| 10/02/2002 | EP1244773A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 10/02/2002 | EP1244708A1 Method for treating inflammation |
| 10/02/2002 | EP1244707A1 Antibodies against signal regulator proteins |
| 10/02/2002 | EP1244705A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 10/02/2002 | EP1244703A1 Novel abcb9 transporter and uses thereof |
| 10/02/2002 | EP1244701A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 10/02/2002 | EP1244700A2 Vesicle trafficking proteins |
| 10/02/2002 | EP1244697A2 Novel polypeptides and nucleic acids encoding same |
| 10/02/2002 | EP1244695A2 Extracellular matrix and cell adhesion proteins as well as genes encoding them |
| 10/02/2002 | EP1244692A2 Compositions and methods for detecting stress-inducible proteins |
| 10/02/2002 | EP1244688A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 10/02/2002 | EP1244686A1 Transforming growth factor alpha hiii |
| 10/02/2002 | EP1244685A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 10/02/2002 | EP1244683A1 21 human secreted proteins |
| 10/02/2002 | EP1244467A1 Phosphoglycerate kinase in the treatment of disease |
| 10/02/2002 | EP1244466A2 Activation and inhibition of the immune system |
| 10/02/2002 | EP1244461A2 INHIBITION OF GSK-3$g(b) |
| 10/02/2002 | EP1244350A2 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal |
| 10/02/2002 | EP1099116B1 Method and kit for the detection of central nervous system tissue in heated meat products |
| 10/02/2002 | EP0861268B1 Inhibitory and non-inhibitory antigen binding polypeptides against human p450 enzymes |
| 10/02/2002 | EP0691988B1 Inhibitor of stem cell proliferation and uses thereof |
| 10/02/2002 | EP0651636B1 Chemotherapy for cancer |
| 10/02/2002 | CN1372599A Plant sterol acryltransferases |
| 10/02/2002 | CN1372594A OX2 receptor homologs |
| 10/02/2002 | CN1372568A Vaccin |
| 10/02/2002 | CN1371995A Human peptide transport protein coding sequence, preparation method and use thereof |
| 10/02/2002 | CN1371917A Liver cance high-expression gene, its coded protein and use |
| 10/02/2002 | CN1371916A Human siali acid conjugated immunoglobulin-like agglutinant, its coding sequence and use |
| 10/02/2002 | CN1371915A Novel human cell endocytic regulatory protein, its coding sequence and use |
| 10/02/2002 | CN1371913A Novel polypeptide-human fasciclin and elongation protein 9.46 and polynucleotide for coding said polypeptide |
| 10/02/2002 | CN1371747A Anti-HIV medicine |
| 10/02/2002 | CN1371690A Vaccine composition for initiating anti-N-glycolyl ganglioside immunoreaction and application thereof |
| 10/01/2002 | WO2001076630A1 Diagnostics and remedies for rheumatoid arthritis |
| 10/01/2002 | US6458934 Grafted complementarity determining regions to mouse monoclonal antibodies; amino acid replacements; autoimmune disease treatment and immunosuppressants; side effect reduction |
| 10/01/2002 | US6458933 Specific for hla class ii invariant chain; side effect reduction of chemotherapy; drug clearance |
| 10/01/2002 | US6458932 Dna cloning; gene expression; genetic engineering |
| 10/01/2002 | US6458839 Modulation of inflammation related to columnar epithelia |
| 10/01/2002 | US6458767 Use of peptides inhibitory for thrombospondin dependent TGF-β activation in the treatment of kidney disease |
| 10/01/2002 | US6458758 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 10/01/2002 | US6458592 Transfecting antibody-producing cell with homology-targeting vector with lox site; genetic engineering and expression |
| 10/01/2002 | US6458575 Useful in the diagnosis, prevention, and treatment of cancer, autoimmune/inflammatory disorders, and reproductive disorders; screening libraries of peptides and antibodies; purification; amino acid sequences |
| 10/01/2002 | US6458572 Phosphatidylglycerophosphate synthase from Staphylococcus aureus |
| 10/01/2002 | US6458564 Amino acid sequence of the protease; for treating imbalance of desquamation |
| 10/01/2002 | US6458552 In vitro method to detect inhibition of enzymes involved in allergies and asthma by mixing enzyme with defined peptide substrates then measuring quantity of product formed in presence and absense of test compound; drug screening |
| 10/01/2002 | US6458527 Using synthetic or recombinant polypeptides as gag antigen; diagnosis of human immunodeficiency virus |
| 10/01/2002 | US6458367 Method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein |
| 10/01/2002 | US6458366 Compounds and methods for diagnosis of tuberculosis |
| 10/01/2002 | US6458360 Soluble complement regulatory molecules |
| 10/01/2002 | US6458356 Antibody-induced apoptosis |
| 10/01/2002 | US6458355 Methods of treating inflammatory disease with anti-IL-8 antibody fragment-polymer conjugates |
| 10/01/2002 | US6458353 Anti-CCR2 antibodies and methods of use therefor |
| 10/01/2002 | US6458350 ULBP DNA and polypeptides |
| 10/01/2002 | US6458349 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing |
| 10/01/2002 | CA2404919A1 Diagnostic and therapeutic agents for rheumatoid arthritis |
| 10/01/2002 | CA2255826C Mutated nonactivating igg2 domains and anti-cd3 antibodies incorporating the same |
| 10/01/2002 | CA2224460C Process for producing gm2 specific antibodies |
| 10/01/2002 | CA2220461C Therapeutic compounds comprised of anti-fc receptor antibodies |
| 10/01/2002 | CA2119930C Production of chimeric antibodies - a combinatorial approach |
| 10/01/2002 | CA2109602C Methods for producing members of specific binding pairs |
| 10/01/2002 | CA2077670C Method for enhancing antibody transport through capillary barriers |
| 10/01/2002 | CA2075358C Multimers of the soluble forms of tnf receptors, their preparation and pharmaceutical compositions containing them |
| 10/01/2002 | CA2073031C Anti-cd4 antibody homologs useful in prophylaxis and treatment of aids, arc and hiv infection |
| 10/01/2002 | CA1341391C Protective peptides derived from human immunodeficiency virus-1 gp160 |
| 09/26/2002 | WO2002075507A2 Anti-bacterial vaccine compositions |
| 09/26/2002 | WO2002075275A2 Polyclonal populations of bispecific molecules and methods of production and uses thereof |
| 09/26/2002 | WO2002074986A2 An early pre-symptomatic prion diagnostic blood test for encephalopathies |
| 09/26/2002 | WO2002074981A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase |
| 09/26/2002 | WO2002074980A2 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 09/26/2002 | WO2002074972A1 Method of assaying lupus anticoagulant and assay reagent |
| 09/26/2002 | WO2002074962A1 Acetyllysine-recognizing monoclonal antibody and process for producing the same |
| 09/26/2002 | WO2002074938A1 Methods for producing antibodies in mammals |
| 09/26/2002 | WO2002074924A2 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 09/26/2002 | WO2002074916A2 Reg-like protein immunoglobulin derived proteins, compositions, methods and uses |
| 09/26/2002 | WO2002074913A2 Nucleic acid-associated proteins |
| 09/26/2002 | WO2002074904A2 Rearranged squamous cell carcinoma antigen genes ii |
| 09/26/2002 | WO2002074812A2 Antibodies for preventing and treating attaching and effacing escherichia coli (aeec) associated diseases |
| 09/26/2002 | WO2002074807A2 Chimpanzee erythropoietin (chepo) - immunoadhesins |
| 09/26/2002 | WO2002074796A2 Histidine phosphatase interacting protein with 240kd |
| 09/26/2002 | WO2002074337A1 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 09/26/2002 | WO2002074335A2 Equine herpesvirus vaccine |
| 09/26/2002 | WO2002074326A2 Urocortin-iii and uses thereof |
| 09/26/2002 | WO2002074324A1 Collagen-binding adhesin from staphylococcus epidermidis and method of use |
| 09/26/2002 | WO2002074251A2 Monoclonal antibody therapy for pancreas cancer |
| 09/26/2002 | WO2002074245A2 Anti-gpe antibodies, their uses, and analytical methods for gpe |
| 09/26/2002 | WO2002074243A2 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders |
| 09/26/2002 | WO2002074240A2 Anti-amyloid antibody based diagnosis and treatment of a neurological disease or disorder |
| 09/26/2002 | WO2002074071A2 Transgenic animal model of ige-mediated allergic responses |
| 09/26/2002 | WO2002062999A8 Proteins and nucleic acids encoding same |
| 09/26/2002 | WO2002046214A3 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/26/2002 | WO2002032945A3 Haemophilus influenzae basb206 gene and protein |
| 09/26/2002 | WO2002030421A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 09/26/2002 | WO2002022685A3 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 09/26/2002 | WO2002016611A3 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 09/26/2002 | WO2002009751A3 COMPOSITIONS FOR INDUCING SELF-SPECIFIC ANTI-IgE ANTIBODIES AND USES THEREOF |
| 09/26/2002 | WO2002000710A3 B7-like molecules and uses thereof |
| 09/26/2002 | WO2001098332A3 Secreted redox proteins |
| 09/26/2002 | WO2001094418A3 Leader peptides for enhancing secretion of recombinant protein from a host cell |